Global Latent TB Infection Testing Market Insights, Forecast to 2029
This report presents an overview of global market for Latent TB Infection Testing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Latent TB Infection Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Latent TB Infection Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Latent TB Infection Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Latent TB Infection Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Latent TB Infection Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC), Pharmstandard (Generium Pharmaceutical), Sanofi S.A./Sanofi Pasteur Ltd., Statens Serum Institut (SSI), Autoimmun Diagnostika (AID) GmbH, Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., Haikou VTI Biological Institute (Vaccine Technologies, Inc.), Immunoshop India Pvt. Ltd. and Qiagen N.V., etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Latent TB Infection Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latent TB Infection Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Latent TB Infection Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Latent TB Infection Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Latent TB Infection Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Latent TB Infection Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Latent TB Infection Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Latent TB Infection Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC), Pharmstandard (Generium Pharmaceutical), Sanofi S.A./Sanofi Pasteur Ltd., Statens Serum Institut (SSI), Autoimmun Diagnostika (AID) GmbH, Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., Haikou VTI Biological Institute (Vaccine Technologies, Inc.), Immunoshop India Pvt. Ltd. and Qiagen N.V., etc.
By Company
- Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
- Pharmstandard (Generium Pharmaceutical)
- Sanofi S.A./Sanofi Pasteur Ltd.
- Statens Serum Institut (SSI)
- Autoimmun Diagnostika (AID) GmbH
- Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
- Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
- Immunoshop India Pvt. Ltd.
- Qiagen N.V.
- Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
- SD Biosensor, Inc.
- Mantoux Test / Tuberculin Skin Test (TST)
- Interferon-Gamma Release Assay (IGRA)
- Hospitals
- Public and Student Health
- Physician Offices and Clinics
- Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Latent TB Infection Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latent TB Infection Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Latent TB Infection Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Software-defined Networking (SDN) Controller Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Open SDN
1.2.3 SDN Via API
1.2.4 SDN Via Overlay
1.3 Market by Application
1.3.1 Global Software-defined Networking (SDN) Controller Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Enterprises
1.3.3 Cloud Service Providers
1.3.4 Telecommunications Service Providers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Software-defined Networking (SDN) Controller Market Perspective (2018-2029)
2.2 Software-defined Networking (SDN) Controller Growth Trends by Region
2.2.1 Global Software-defined Networking (SDN) Controller Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Software-defined Networking (SDN) Controller Historic Market Size by Region (2018-2023)
2.2.3 Software-defined Networking (SDN) Controller Forecasted Market Size by Region (2024-2029)
2.3 Software-defined Networking (SDN) Controller Market Dynamics
2.3.1 Software-defined Networking (SDN) Controller Industry Trends
2.3.2 Software-defined Networking (SDN) Controller Market Drivers
2.3.3 Software-defined Networking (SDN) Controller Market Challenges
2.3.4 Software-defined Networking (SDN) Controller Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Software-defined Networking (SDN) Controller Players by Revenue
3.1.1 Global Top Software-defined Networking (SDN) Controller Players by Revenue (2018-2023)
3.1.2 Global Software-defined Networking (SDN) Controller Revenue Market Share by Players (2018-2023)
3.2 Global Software-defined Networking (SDN) Controller Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Software-defined Networking (SDN) Controller Revenue
3.4 Global Software-defined Networking (SDN) Controller Market Concentration Ratio
3.4.1 Global Software-defined Networking (SDN) Controller Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Software-defined Networking (SDN) Controller Revenue in 2022
3.5 Software-defined Networking (SDN) Controller Key Players Head office and Area Served
3.6 Key Players Software-defined Networking (SDN) Controller Product Solution and Service
3.7 Date of Enter into Software-defined Networking (SDN) Controller Market
3.8 Mergers & Acquisitions, Expansion Plans
4 SOFTWARE-DEFINED NETWORKING (SDN) CONTROLLER BREAKDOWN DATA BY TYPE
4.1 Global Software-defined Networking (SDN) Controller Historic Market Size by Type (2018-2023)
4.2 Global Software-defined Networking (SDN) Controller Forecasted Market Size by Type (2024-2029)
5 SOFTWARE-DEFINED NETWORKING (SDN) CONTROLLER BREAKDOWN DATA BY APPLICATION
5.1 Global Software-defined Networking (SDN) Controller Historic Market Size by Application (2018-2023)
5.2 Global Software-defined Networking (SDN) Controller Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Software-defined Networking (SDN) Controller Market Size (2018-2029)
6.2 North America Software-defined Networking (SDN) Controller Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Software-defined Networking (SDN) Controller Market Size by Country (2018-2023)
6.4 North America Software-defined Networking (SDN) Controller Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Software-defined Networking (SDN) Controller Market Size (2018-2029)
7.2 Europe Software-defined Networking (SDN) Controller Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Software-defined Networking (SDN) Controller Market Size by Country (2018-2023)
7.4 Europe Software-defined Networking (SDN) Controller Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Software-defined Networking (SDN) Controller Market Size (2018-2029)
8.2 Asia-Pacific Software-defined Networking (SDN) Controller Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Software-defined Networking (SDN) Controller Market Size by Region (2018-2023)
8.4 Asia-Pacific Software-defined Networking (SDN) Controller Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Software-defined Networking (SDN) Controller Market Size (2018-2029)
9.2 Latin America Software-defined Networking (SDN) Controller Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Software-defined Networking (SDN) Controller Market Size by Country (2018-2023)
9.4 Latin America Software-defined Networking (SDN) Controller Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Software-defined Networking (SDN) Controller Market Size (2018-2029)
10.2 Middle East & Africa Software-defined Networking (SDN) Controller Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Software-defined Networking (SDN) Controller Market Size by Country (2018-2023)
10.4 Middle East & Africa Software-defined Networking (SDN) Controller Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Cisco
11.1.1 Cisco Company Detail
11.1.2 Cisco Business Overview
11.1.3 Cisco Software-defined Networking (SDN) Controller Introduction
11.1.4 Cisco Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.1.5 Cisco Recent Development
11.2 Juniper Networks
11.2.1 Juniper Networks Company Detail
11.2.2 Juniper Networks Business Overview
11.2.3 Juniper Networks Software-defined Networking (SDN) Controller Introduction
11.2.4 Juniper Networks Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.2.5 Juniper Networks Recent Development
11.3 VMware
11.3.1 VMware Company Detail
11.3.2 VMware Business Overview
11.3.3 VMware Software-defined Networking (SDN) Controller Introduction
11.3.4 VMware Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.3.5 VMware Recent Development
11.4 Nokia
11.4.1 Nokia Company Detail
11.4.2 Nokia Business Overview
11.4.3 Nokia Software-defined Networking (SDN) Controller Introduction
11.4.4 Nokia Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.4.5 Nokia Recent Development
11.5 Big Switch Networks
11.5.1 Big Switch Networks Company Detail
11.5.2 Big Switch Networks Business Overview
11.5.3 Big Switch Networks Software-defined Networking (SDN) Controller Introduction
11.5.4 Big Switch Networks Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.5.5 Big Switch Networks Recent Development
11.6 Cumulus Networks
11.6.1 Cumulus Networks Company Detail
11.6.2 Cumulus Networks Business Overview
11.6.3 Cumulus Networks Software-defined Networking (SDN) Controller Introduction
11.6.4 Cumulus Networks Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.6.5 Cumulus Networks Recent Development
11.7 Hewlett Packard Enterprise
11.7.1 Hewlett Packard Enterprise Company Detail
11.7.2 Hewlett Packard Enterprise Business Overview
11.7.3 Hewlett Packard Enterprise Software-defined Networking (SDN) Controller Introduction
11.7.4 Hewlett Packard Enterprise Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.7.5 Hewlett Packard Enterprise Recent Development
11.8 Nuage Networks
11.8.1 Nuage Networks Company Detail
11.8.2 Nuage Networks Business Overview
11.8.3 Nuage Networks Software-defined Networking (SDN) Controller Introduction
11.8.4 Nuage Networks Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.8.5 Nuage Networks Recent Development
11.9 Pica8
11.9.1 Pica8 Company Detail
11.9.2 Pica8 Business Overview
11.9.3 Pica8 Software-defined Networking (SDN) Controller Introduction
11.9.4 Pica8 Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.9.5 Pica8 Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Software-defined Networking (SDN) Controller Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Open SDN
1.2.3 SDN Via API
1.2.4 SDN Via Overlay
1.3 Market by Application
1.3.1 Global Software-defined Networking (SDN) Controller Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Enterprises
1.3.3 Cloud Service Providers
1.3.4 Telecommunications Service Providers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Software-defined Networking (SDN) Controller Market Perspective (2018-2029)
2.2 Software-defined Networking (SDN) Controller Growth Trends by Region
2.2.1 Global Software-defined Networking (SDN) Controller Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Software-defined Networking (SDN) Controller Historic Market Size by Region (2018-2023)
2.2.3 Software-defined Networking (SDN) Controller Forecasted Market Size by Region (2024-2029)
2.3 Software-defined Networking (SDN) Controller Market Dynamics
2.3.1 Software-defined Networking (SDN) Controller Industry Trends
2.3.2 Software-defined Networking (SDN) Controller Market Drivers
2.3.3 Software-defined Networking (SDN) Controller Market Challenges
2.3.4 Software-defined Networking (SDN) Controller Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Software-defined Networking (SDN) Controller Players by Revenue
3.1.1 Global Top Software-defined Networking (SDN) Controller Players by Revenue (2018-2023)
3.1.2 Global Software-defined Networking (SDN) Controller Revenue Market Share by Players (2018-2023)
3.2 Global Software-defined Networking (SDN) Controller Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Software-defined Networking (SDN) Controller Revenue
3.4 Global Software-defined Networking (SDN) Controller Market Concentration Ratio
3.4.1 Global Software-defined Networking (SDN) Controller Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Software-defined Networking (SDN) Controller Revenue in 2022
3.5 Software-defined Networking (SDN) Controller Key Players Head office and Area Served
3.6 Key Players Software-defined Networking (SDN) Controller Product Solution and Service
3.7 Date of Enter into Software-defined Networking (SDN) Controller Market
3.8 Mergers & Acquisitions, Expansion Plans
4 SOFTWARE-DEFINED NETWORKING (SDN) CONTROLLER BREAKDOWN DATA BY TYPE
4.1 Global Software-defined Networking (SDN) Controller Historic Market Size by Type (2018-2023)
4.2 Global Software-defined Networking (SDN) Controller Forecasted Market Size by Type (2024-2029)
5 SOFTWARE-DEFINED NETWORKING (SDN) CONTROLLER BREAKDOWN DATA BY APPLICATION
5.1 Global Software-defined Networking (SDN) Controller Historic Market Size by Application (2018-2023)
5.2 Global Software-defined Networking (SDN) Controller Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Software-defined Networking (SDN) Controller Market Size (2018-2029)
6.2 North America Software-defined Networking (SDN) Controller Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Software-defined Networking (SDN) Controller Market Size by Country (2018-2023)
6.4 North America Software-defined Networking (SDN) Controller Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Software-defined Networking (SDN) Controller Market Size (2018-2029)
7.2 Europe Software-defined Networking (SDN) Controller Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Software-defined Networking (SDN) Controller Market Size by Country (2018-2023)
7.4 Europe Software-defined Networking (SDN) Controller Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Software-defined Networking (SDN) Controller Market Size (2018-2029)
8.2 Asia-Pacific Software-defined Networking (SDN) Controller Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Software-defined Networking (SDN) Controller Market Size by Region (2018-2023)
8.4 Asia-Pacific Software-defined Networking (SDN) Controller Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Software-defined Networking (SDN) Controller Market Size (2018-2029)
9.2 Latin America Software-defined Networking (SDN) Controller Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Software-defined Networking (SDN) Controller Market Size by Country (2018-2023)
9.4 Latin America Software-defined Networking (SDN) Controller Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Software-defined Networking (SDN) Controller Market Size (2018-2029)
10.2 Middle East & Africa Software-defined Networking (SDN) Controller Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Software-defined Networking (SDN) Controller Market Size by Country (2018-2023)
10.4 Middle East & Africa Software-defined Networking (SDN) Controller Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Cisco
11.1.1 Cisco Company Detail
11.1.2 Cisco Business Overview
11.1.3 Cisco Software-defined Networking (SDN) Controller Introduction
11.1.4 Cisco Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.1.5 Cisco Recent Development
11.2 Juniper Networks
11.2.1 Juniper Networks Company Detail
11.2.2 Juniper Networks Business Overview
11.2.3 Juniper Networks Software-defined Networking (SDN) Controller Introduction
11.2.4 Juniper Networks Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.2.5 Juniper Networks Recent Development
11.3 VMware
11.3.1 VMware Company Detail
11.3.2 VMware Business Overview
11.3.3 VMware Software-defined Networking (SDN) Controller Introduction
11.3.4 VMware Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.3.5 VMware Recent Development
11.4 Nokia
11.4.1 Nokia Company Detail
11.4.2 Nokia Business Overview
11.4.3 Nokia Software-defined Networking (SDN) Controller Introduction
11.4.4 Nokia Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.4.5 Nokia Recent Development
11.5 Big Switch Networks
11.5.1 Big Switch Networks Company Detail
11.5.2 Big Switch Networks Business Overview
11.5.3 Big Switch Networks Software-defined Networking (SDN) Controller Introduction
11.5.4 Big Switch Networks Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.5.5 Big Switch Networks Recent Development
11.6 Cumulus Networks
11.6.1 Cumulus Networks Company Detail
11.6.2 Cumulus Networks Business Overview
11.6.3 Cumulus Networks Software-defined Networking (SDN) Controller Introduction
11.6.4 Cumulus Networks Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.6.5 Cumulus Networks Recent Development
11.7 Hewlett Packard Enterprise
11.7.1 Hewlett Packard Enterprise Company Detail
11.7.2 Hewlett Packard Enterprise Business Overview
11.7.3 Hewlett Packard Enterprise Software-defined Networking (SDN) Controller Introduction
11.7.4 Hewlett Packard Enterprise Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.7.5 Hewlett Packard Enterprise Recent Development
11.8 Nuage Networks
11.8.1 Nuage Networks Company Detail
11.8.2 Nuage Networks Business Overview
11.8.3 Nuage Networks Software-defined Networking (SDN) Controller Introduction
11.8.4 Nuage Networks Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.8.5 Nuage Networks Recent Development
11.9 Pica8
11.9.1 Pica8 Company Detail
11.9.2 Pica8 Business Overview
11.9.3 Pica8 Software-defined Networking (SDN) Controller Introduction
11.9.4 Pica8 Revenue in Software-defined Networking (SDN) Controller Business (2018-2023)
11.9.5 Pica8 Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Latent TB Infection Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Mantoux Test / Tuberculin Skin Test (TST)
Table 3. Key Players of Interferon-Gamma Release Assay (IGRA)
Table 4. Global Latent TB Infection Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Latent TB Infection Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Latent TB Infection Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Latent TB Infection Testing Market Share by Region (2018-2023)
Table 8. Global Latent TB Infection Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Latent TB Infection Testing Market Share by Region (2024-2029)
Table 10. Latent TB Infection Testing Market Trends
Table 11. Latent TB Infection Testing Market Drivers
Table 12. Latent TB Infection Testing Market Challenges
Table 13. Latent TB Infection Testing Market Restraints
Table 14. Global Latent TB Infection Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Latent TB Infection Testing Revenue Share by Players (2018-2023)
Table 16. Global Top Latent TB Infection Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent TB Infection Testing as of 2022)
Table 17. Global Latent TB Infection Testing Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Latent TB Infection Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Latent TB Infection Testing, Headquarters and Area Served
Table 20. Global Key Players of Latent TB Infection Testing, Product and Application
Table 21. Global Key Players of Latent TB Infection Testing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Latent TB Infection Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Latent TB Infection Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Latent TB Infection Testing Revenue Market Share by Type (2024-2029)
Table 27. Global Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Latent TB Infection Testing Revenue Share by Application (2018-2023)
Table 29. Global Latent TB Infection Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Latent TB Infection Testing Revenue Share by Application (2024-2029)
Table 31. North America Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Latent TB Infection Testing Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Latent TB Infection Testing Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Latent TB Infection Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Latent TB Infection Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Latent TB Infection Testing Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Latent TB Infection Testing Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Latent TB Infection Testing Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Latent TB Infection Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Latent TB Infection Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Latent TB Infection Testing Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Latent TB Infection Testing Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Latent TB Infection Testing Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Latent TB Infection Testing Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Latent TB Infection Testing Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Latent TB Infection Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Latent TB Infection Testing Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Latent TB Infection Testing Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Latent TB Infection Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Country (2024-2029) & (US$ Million)
Table 63. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Details
Table 64. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
Table 65. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product
Table 66. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 67. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Developments
Table 68. Pharmstandard (Generium Pharmaceutical) Company Details
Table 69. Pharmstandard (Generium Pharmaceutical) Business Overview
Table 70. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product
Table 71. Pharmstandard (Generium Pharmaceutical) Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 72. Pharmstandard (Generium Pharmaceutical) Recent Developments
Table 73. Sanofi S.A./Sanofi Pasteur Ltd. Company Details
Table 74. Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
Table 75. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product
Table 76. Sanofi S.A./Sanofi Pasteur Ltd. Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 77. Sanofi S.A./Sanofi Pasteur Ltd. Recent Developments
Table 78. Statens Serum Institut (SSI) Company Details
Table 79. Statens Serum Institut (SSI) Business Overview
Table 80. Statens Serum Institut (SSI) Latent TB Infection Testing Product
Table 81. Statens Serum Institut (SSI) Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 82. Statens Serum Institut (SSI) Recent Developments
Table 83. Autoimmun Diagnostika (AID) GmbH Company Details
Table 84. Autoimmun Diagnostika (AID) GmbH Business Overview
Table 85. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product
Table 86. Autoimmun Diagnostika (AID) GmbH Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 87. Autoimmun Diagnostika (AID) GmbH Recent Developments
Table 88. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Details
Table 89. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
Table 90. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product
Table 91. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 92. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Developments
Table 93. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Details
Table 94. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
Table 95. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product
Table 96. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 97. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Developments
Table 98. Immunoshop India Pvt. Ltd. Company Details
Table 99. Immunoshop India Pvt. Ltd. Business Overview
Table 100. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product
Table 101. Immunoshop India Pvt. Ltd. Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 102. Immunoshop India Pvt. Ltd. Recent Developments
Table 103. Qiagen N.V. Company Details
Table 104. Qiagen N.V. Business Overview
Table 105. Qiagen N.V. Latent TB Infection Testing Product
Table 106. Qiagen N.V. Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 107. Qiagen N.V. Recent Developments
Table 108. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Details
Table 109. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
Table 110. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product
Table 111. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 112. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Developments
Table 113. SD Biosensor, Inc. Company Details
Table 114. SD Biosensor, Inc. Business Overview
Table 115. SD Biosensor, Inc. Latent TB Infection Testing Product
Table 116. SD Biosensor, Inc. Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 117. SD Biosensor, Inc. Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 1. Global Latent TB Infection Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Mantoux Test / Tuberculin Skin Test (TST)
Table 3. Key Players of Interferon-Gamma Release Assay (IGRA)
Table 4. Global Latent TB Infection Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Latent TB Infection Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Latent TB Infection Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Latent TB Infection Testing Market Share by Region (2018-2023)
Table 8. Global Latent TB Infection Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Latent TB Infection Testing Market Share by Region (2024-2029)
Table 10. Latent TB Infection Testing Market Trends
Table 11. Latent TB Infection Testing Market Drivers
Table 12. Latent TB Infection Testing Market Challenges
Table 13. Latent TB Infection Testing Market Restraints
Table 14. Global Latent TB Infection Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Latent TB Infection Testing Revenue Share by Players (2018-2023)
Table 16. Global Top Latent TB Infection Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent TB Infection Testing as of 2022)
Table 17. Global Latent TB Infection Testing Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Latent TB Infection Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Latent TB Infection Testing, Headquarters and Area Served
Table 20. Global Key Players of Latent TB Infection Testing, Product and Application
Table 21. Global Key Players of Latent TB Infection Testing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Latent TB Infection Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Latent TB Infection Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Latent TB Infection Testing Revenue Market Share by Type (2024-2029)
Table 27. Global Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Latent TB Infection Testing Revenue Share by Application (2018-2023)
Table 29. Global Latent TB Infection Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Latent TB Infection Testing Revenue Share by Application (2024-2029)
Table 31. North America Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Latent TB Infection Testing Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Latent TB Infection Testing Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Latent TB Infection Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Latent TB Infection Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Latent TB Infection Testing Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Latent TB Infection Testing Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Latent TB Infection Testing Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Latent TB Infection Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Latent TB Infection Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Latent TB Infection Testing Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Latent TB Infection Testing Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Latent TB Infection Testing Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Latent TB Infection Testing Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Latent TB Infection Testing Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Latent TB Infection Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Latent TB Infection Testing Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Latent TB Infection Testing Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Latent TB Infection Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size by Country (2024-2029) & (US$ Million)
Table 63. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Details
Table 64. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
Table 65. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product
Table 66. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 67. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Developments
Table 68. Pharmstandard (Generium Pharmaceutical) Company Details
Table 69. Pharmstandard (Generium Pharmaceutical) Business Overview
Table 70. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product
Table 71. Pharmstandard (Generium Pharmaceutical) Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 72. Pharmstandard (Generium Pharmaceutical) Recent Developments
Table 73. Sanofi S.A./Sanofi Pasteur Ltd. Company Details
Table 74. Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
Table 75. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product
Table 76. Sanofi S.A./Sanofi Pasteur Ltd. Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 77. Sanofi S.A./Sanofi Pasteur Ltd. Recent Developments
Table 78. Statens Serum Institut (SSI) Company Details
Table 79. Statens Serum Institut (SSI) Business Overview
Table 80. Statens Serum Institut (SSI) Latent TB Infection Testing Product
Table 81. Statens Serum Institut (SSI) Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 82. Statens Serum Institut (SSI) Recent Developments
Table 83. Autoimmun Diagnostika (AID) GmbH Company Details
Table 84. Autoimmun Diagnostika (AID) GmbH Business Overview
Table 85. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product
Table 86. Autoimmun Diagnostika (AID) GmbH Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 87. Autoimmun Diagnostika (AID) GmbH Recent Developments
Table 88. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Details
Table 89. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
Table 90. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product
Table 91. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 92. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Developments
Table 93. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Details
Table 94. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
Table 95. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product
Table 96. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 97. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Developments
Table 98. Immunoshop India Pvt. Ltd. Company Details
Table 99. Immunoshop India Pvt. Ltd. Business Overview
Table 100. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product
Table 101. Immunoshop India Pvt. Ltd. Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 102. Immunoshop India Pvt. Ltd. Recent Developments
Table 103. Qiagen N.V. Company Details
Table 104. Qiagen N.V. Business Overview
Table 105. Qiagen N.V. Latent TB Infection Testing Product
Table 106. Qiagen N.V. Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 107. Qiagen N.V. Recent Developments
Table 108. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Details
Table 109. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
Table 110. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product
Table 111. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 112. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Developments
Table 113. SD Biosensor, Inc. Company Details
Table 114. SD Biosensor, Inc. Business Overview
Table 115. SD Biosensor, Inc. Latent TB Infection Testing Product
Table 116. SD Biosensor, Inc. Revenue in Latent TB Infection Testing Business (2018-2023) & (US$ Million)
Table 117. SD Biosensor, Inc. Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Latent TB Infection Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Latent TB Infection Testing Market Share by Type: 2022 VS 2029
Figure 3. Mantoux Test / Tuberculin Skin Test (TST) Features
Figure 4. Interferon-Gamma Release Assay (IGRA) Features
Figure 5. Global Latent TB Infection Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Latent TB Infection Testing Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Public and Student Health Case Studies
Figure 9. Physician Offices and Clinics Case Studies
Figure 10. Others (Military, Correctional Facilities, Chronic Care Homes, and Others) Case Studies
Figure 11. Latent TB Infection Testing Report Years Considered
Figure 12. Global Latent TB Infection Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Latent TB Infection Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Latent TB Infection Testing Market Share by Region: 2022 VS 2029
Figure 15. Global Latent TB Infection Testing Market Share by Players in 2022
Figure 16. Global Top Latent TB Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent TB Infection Testing as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Latent TB Infection Testing Revenue in 2022
Figure 18. North America Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Latent TB Infection Testing Market Share by Type (2018-2029)
Figure 20. North America Latent TB Infection Testing Market Share by Application (2018-2029)
Figure 21. North America Latent TB Infection Testing Market Share by Country (2018-2029)
Figure 22. United States Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Latent TB Infection Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Latent TB Infection Testing Market Share by Type (2018-2029)
Figure 26. Europe Latent TB Infection Testing Market Share by Application (2018-2029)
Figure 27. Europe Latent TB Infection Testing Market Share by Country (2018-2029)
Figure 28. Germany Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Latent TB Infection Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Latent TB Infection Testing Market Share by Type (2018-2029)
Figure 36. China Latent TB Infection Testing Market Share by Application (2018-2029)
Figure 37. Asia Latent TB Infection Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Latent TB Infection Testing Market Share by Type (2018-2029)
Figure 39. Asia Latent TB Infection Testing Market Share by Application (2018-2029)
Figure 40. Asia Latent TB Infection Testing Market Share by Region (2018-2029)
Figure 41. Japan Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Latent TB Infection Testing Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Latent TB Infection Testing Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Latent TB Infection Testing Market Share by Country (2018-2029)
Figure 51. Brazil Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 58. Pharmstandard (Generium Pharmaceutical) Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 59. Sanofi S.A./Sanofi Pasteur Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 60. Statens Serum Institut (SSI) Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 61. Autoimmun Diagnostika (AID) GmbH Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 62. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 63. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 64. Immunoshop India Pvt. Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 65. Qiagen N.V. Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 66. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 67. SD Biosensor, Inc. Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Figure 1. Global Latent TB Infection Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Latent TB Infection Testing Market Share by Type: 2022 VS 2029
Figure 3. Mantoux Test / Tuberculin Skin Test (TST) Features
Figure 4. Interferon-Gamma Release Assay (IGRA) Features
Figure 5. Global Latent TB Infection Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Latent TB Infection Testing Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Public and Student Health Case Studies
Figure 9. Physician Offices and Clinics Case Studies
Figure 10. Others (Military, Correctional Facilities, Chronic Care Homes, and Others) Case Studies
Figure 11. Latent TB Infection Testing Report Years Considered
Figure 12. Global Latent TB Infection Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Latent TB Infection Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Latent TB Infection Testing Market Share by Region: 2022 VS 2029
Figure 15. Global Latent TB Infection Testing Market Share by Players in 2022
Figure 16. Global Top Latent TB Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent TB Infection Testing as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Latent TB Infection Testing Revenue in 2022
Figure 18. North America Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Latent TB Infection Testing Market Share by Type (2018-2029)
Figure 20. North America Latent TB Infection Testing Market Share by Application (2018-2029)
Figure 21. North America Latent TB Infection Testing Market Share by Country (2018-2029)
Figure 22. United States Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Latent TB Infection Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Latent TB Infection Testing Market Share by Type (2018-2029)
Figure 26. Europe Latent TB Infection Testing Market Share by Application (2018-2029)
Figure 27. Europe Latent TB Infection Testing Market Share by Country (2018-2029)
Figure 28. Germany Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Latent TB Infection Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Latent TB Infection Testing Market Share by Type (2018-2029)
Figure 36. China Latent TB Infection Testing Market Share by Application (2018-2029)
Figure 37. Asia Latent TB Infection Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Latent TB Infection Testing Market Share by Type (2018-2029)
Figure 39. Asia Latent TB Infection Testing Market Share by Application (2018-2029)
Figure 40. Asia Latent TB Infection Testing Market Share by Region (2018-2029)
Figure 41. Japan Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Latent TB Infection Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Latent TB Infection Testing Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Latent TB Infection Testing Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Latent TB Infection Testing Market Share by Country (2018-2029)
Figure 51. Brazil Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Latent TB Infection Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 58. Pharmstandard (Generium Pharmaceutical) Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 59. Sanofi S.A./Sanofi Pasteur Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 60. Statens Serum Institut (SSI) Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 61. Autoimmun Diagnostika (AID) GmbH Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 62. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 63. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 64. Immunoshop India Pvt. Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 65. Qiagen N.V. Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 66. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 67. SD Biosensor, Inc. Revenue Growth Rate in Latent TB Infection Testing Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
